l&t BUY at 3400 TARGET 3500+
Please follow and like us:
l&t BUY at 3400 TARGET 3500+
Related Posts
SIP Investors’ Confidence on the Rise
SIP Book Growth: Investors’ Confidence on the Rise Systematic Investment Plans (SIPs) have become increasingly popular among investors, reflected by the steady month-on-month growth in […]
Nifty 50 Resistance 22689 – 22719 Support 22540 – 22430 Nifty Bank Resistance 49440 – 49688 Support 49040 – 48840 Nifty 50 Resistance 22689 – 22719 Support 22540 – 22430 Nifty Bank Resistance 49440 – 49688 Support 49040 – 48840
Nifty 50 Resistance 22689 – 22719Support 22540 – 22430Nifty BankResistance 49440 – 49688Support 49040 – 48840 Nifty 50 Resistance 22689 – 22719 Support 22540 – […]
NATCO PHARMA: CO ANNOUNCES THAT MYLAN PHARMA INC. AND NOVO NORDISK HAVE REACHED A SETTLEMENT OF THE U.S. PATENT LITIGATION RELATED TO GENERIC OZEMPIC (SEMAGLUTIDE). #FinancialNews #Financial MarketTrends https://earnfree.in/latest NATCO PHARMA: CO ANNOUNCES THAT MYLAN PHARMA INC. AND NOVO NORDISK HAVE REACHED A SETTLEMENT OF THE U.S. PATENT LITIGATION RELATED TO GENERIC OZEMPIC (SEMAGLUTIDE). #FinancialNews #Financial MarketTrends https://ift.tt/jmZBx8V
NATCO PHARMA: CO ANNOUNCES THAT MYLAN PHARMA INC. AND NOVO NORDISK HAVE REACHED A SETTLEMENT OF THE U.S. PATENT LITIGATION RELATED TO GENERIC OZEMPIC (SEMAGLUTIDE). […]